ABVC BioPharma (ABVC) Stock Chart & Stock Price History → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free ABVC Stock Alerts $1.07 +0.01 (+0.94%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media ABVC BioPharma Stock Price Performance5 Day Performance-0.93%1 Month Performance+8.07%3 Month Performance-10.83%6 Month Performance-36.69%Year-To-Date Performance-7.76%1 Year Performance-85.33% Ad Stansberry Research41 banks launch ‘crypto dollar’Everyone knows the US financial system is in the middle of a radical change... The White House wants an all-digital dollar. Plus at least 41 major banks (see if your bank is one of them right here).Here's how you capitalize (including #1 crypto to play it). ABVC Stock Chart for Monday, May, 20, 2024 ABVC Chart by TradingView ABVC BioPharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$1.06$1.07+0.94%$1.09$1.06112,508 shs$11.30 million05/16/2024$1.08$1.06-1.85%$1.10$1.05149,979 shs$11.19 million05/15/2024$1.08$1.08$1.12$1.06326,851 shs$11.41 million05/14/2024$1.07$1.08+0.93%$1.09$1.05242,038 shs$11.41 million05/13/2024$1.06$1.07+0.94%$1.14$1.06186,737 shs$11.30 million05/10/2024$1.10$1.06-3.64%$1.09$1.05206,638 shs$11.19 millionThe Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now.05/09/2024$1.11$1.10-0.90%$1.24$1.061.31 million shs$11.62 million05/08/2024$1.06$1.11+4.72%$1.13$1.04553,806 shs$11.72 million05/07/2024$1.08$1.06-1.85%$1.08$1.03259,997 shs$11.19 million05/06/2024$1.08$1.08$1.09$1.03735,481 shs$11.41 million05/03/2024$1.15$1.08-6.09%$1.15$1.07413,386 shs$11.41 million05/02/2024$1.13$1.15+1.77%$1.17$1.10308,204 shs$12.14 million05/01/2024$1.25$1.13-9.60%$1.23$1.05980,321 shs$11.93 million04/30/2024$1.40$1.25-10.71%$1.40$1.25752,769 shs$13.20 million04/29/2024$1.42$1.40-1.41%$1.45$1.301.74 million shs$14.78 million04/26/2024$1.59$1.42-10.69%$1.57$1.402.02 million shs$15.00 million04/25/2024$1.48$1.59+7.43%$1.73$1.365.33 million shs$16.79 million04/24/2024$1.35$1.48+9.63%$1.50$1.286.45 million shs$15.63 million04/23/2024$1.04$1.35+29.81%$1.37$1.007.67 million shs$14.26 million04/22/2024$0.99$1.04+5.04%$1.04$0.94307,916 shs$10.98 million04/19/2024$1.05$0.99-5.70%$1.04$0.97167,634 shs$10.46 million04/18/2024$1.02$1.05+2.94%$1.07$0.94459,059 shs$11.09 million04/17/2024$1.12$1.02-8.93%$1.19$1.001.78 million shs$10.77 million04/16/2024$1.09$1.12+2.75%$1.13$1.05109,769 shs$11.83 million04/15/2024$1.09$1.09$1.11$1.05218,100 shs$11.51 million04/12/2024$1.15$1.09-5.22%$1.15$1.08222,465 shs$11.51 million04/11/2024$1.14$1.15+0.88%$1.17$1.10265,141 shs$12.14 million04/10/2024$1.18$1.14-3.39%$1.30$1.063.78 million shs$12.04 million04/09/2024$1.25$1.18-5.60%$1.26$1.17249,003 shs$12.46 million04/08/2024$1.27$1.25-1.57%$1.31$1.25156,549 shs$13.20 million04/05/2024$1.28$1.27-0.78%$1.30$1.2567,591 shs$13.41 million04/04/2024$1.29$1.28-0.78%$1.31$1.25114,803 shs$13.52 million04/03/2024$1.29$1.29$1.30$1.24126,235 shs$13.62 million04/02/2024$1.37$1.29-5.84%$1.35$1.25202,976 shs$13.62 million04/01/2024$1.31$1.37+4.58%$1.41$1.28645,232 shs$14.47 million03/29/2024$1.31$1.31$1.31$1.16678,552 shs$13.83 million03/28/2024$1.20$1.31+9.17%$1.31$1.16670,304 shs$13.83 million03/27/2024$1.28$1.20-6.25%$1.33$1.181.43 million shs$12.67 million03/26/2024$1.05$1.28+21.90%$1.45$1.1527.15 million shs$13.52 million03/25/2024$1.07$1.05-1.87%$1.06$1.03106,302 shs$11.09 millionThe Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now.03/22/2024$1.06$1.07+0.94%$1.08$1.0662,105 shs$8.28 million03/21/2024$1.08$1.06-1.85%$1.11$1.0683,561 shs$8.20 million03/20/2024$1.12$1.08-3.57%$1.13$1.06190,875 shs$8.36 million03/19/2024$1.16$1.12-3.45%$1.17$1.10108,502 shs$8.67 million03/18/2024$1.17$1.16-0.85%$1.18$1.1464,098 shs$8.98 million03/15/2024$1.20$1.17-2.50%$1.22$1.17127,997 shs$9.06 million03/14/2024$1.23$1.20-2.44%$1.25$1.2064,665 shs$9.29 million03/13/2024$1.26$1.23-2.38%$1.25$1.2176,848 shs$9.52 million03/12/2024$1.22$1.26+3.28%$1.29$1.2159,771 shs$9.76 million03/11/2024$1.25$1.22-2.40%$1.26$1.2271,572 shs$9.44 million03/08/2024$1.25$1.25$1.29$1.2455,751 shs$9.68 million03/07/2024$1.24$1.25+0.81%$1.26$1.2139,513 shs$9.60 million03/06/2024$1.21$1.24+2.48%$1.25$1.2085,387 shs$9.60 million03/05/2024$1.24$1.21-2.42%$1.25$1.2059,411 shs$9.37 million03/04/2024$1.18$1.24+5.08%$1.27$1.19148,854 shs$9.60 million03/01/2024$1.21$1.18-2.48%$1.22$1.15135,775 shs$9.13 million02/29/2024$1.22$1.21-0.41%$1.23$1.1893,283 shs$9.37 million02/28/2024$1.23$1.22-1.22%$1.24$1.2193,737 shs$9.40 million02/27/2024$1.24$1.23-0.81%$1.25$1.2259,773 shs$9.53 million02/26/2024$1.20$1.24+3.33%$1.25$1.1880,883 shs$9.60 million02/23/2024$1.21$1.20-0.83%$1.21$1.1678,389 shs$9.29 million02/22/2024$1.19$1.21+1.68%$1.27$1.1746,426 shs$9.37 million02/21/2024$1.20$1.19-0.83%$1.21$1.15142,041 shs$9.21 million02/20/2024$1.27$1.20-5.51%$1.28$1.19167,158 shs$9.29 million02/19/2024$1.27$1.27$1.29$1.25176,900 shs$9.83 million Related Companies: Elevai Labs Stock Chart Akari Therapeutics Stock Chart Eterna Therapeutics Stock Chart Avalo Therapeutics Stock Chart MIRA Pharmaceuticals Stock Chart Moleculin Biotech Stock Chart Molecular Templates Stock Chart Kiora Pharmaceuticals Stock Chart Guardion Health Sciences Stock Chart Monopar Therapeutics Stock Chart This page (NASDAQ:ABVC) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDems have chosen Biden replacement?Paradigm PressBill Gates is all about this tiny $2 stockTimothy Sykes Adding Choose a watchlist: Watchlist My Default Watchlist Adding ABVC BioPharma, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.